Chrzastawa Mala, Poland

Aleksandra Drozd

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aleksandra Drozd: Innovator in Pharmaceutical Preparations

Introduction: Aleksandra Drozd is a remarkable inventor based in Chrzastawa Mala, Poland. With a focus on pharmaceutical innovations, she has contributed to the development of advanced drug formulations. Her dedication to scientific progress is exemplified by her patented process that targets specific medical conditions.

Latest Patents: Drozd holds a patent for a "Process for preparation of an enteric coated granulate comprising dimethyl fumarate." This invention describes a process for creating an oral pharmaceutical preparation in the form of enteric coated granulate, which includes dimethyl fumarate alongside pharmaceutically acceptable excipients. The patent signifies a significant advancement in the treatment of multiple sclerosis, offering a novel approach through her innovative formulation.

Career Highlights: Throughout her career, Aleksandra has established herself as a key figure in the pharmaceutical industry. She works at Polpharma, a prominent pharmaceutical company known for developing effective medications. Her skills and expertise have allowed her to contribute substantially to research and development within the organization.

Collaborations: Aleksandra collaborates with talented colleagues such as Przemyslaw Skoczen and Marek Cichocki. These relationships enhance her research capabilities and allow for a collaborative approach to developing new pharmaceutical solutions.

Conclusion: Aleksandra Drozd's innovation in the field of pharmaceuticals highlights the importance of dedicated inventors in advancing medical treatments. Her contributions through her patent not only reflect her individual talent but also underscore the collaborative efforts within the industry. As she continues her work at Polpharma, her efforts may lead to further breakthroughs in the treatment of multiple sclerosis and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…